Study of Aripiprazole in the Treatment of Children and Adolescents With Autistic Disorder (AD)

Clinical trial NCT00337571 · COMPLETED

Trial details

NCT number: NCT00337571
Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Behavioral Symptoms Autistic Disorder

Start date: 2006-06-01
Primary completion: 2008-06-01
Enrollment: 218

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.